BEIJING (Xinhua): China will include nucleic acid testing and antibody testing for Covid-19 (coronavirus) and related consumables in provincial medical insurance catalogues, according to the National Healthcare Security Administration.
The move is designed to reduce testing cost to facilitate regular epidemic control and resumption of work, production, school and business operation, according to a circular issued by the administration.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!